Pharma Times

MAY 23, 2022

It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency

121

121

pharmaphorum

MAY 25, 2022

US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world’s poorest countries – including new launches. The initiative will focus on infectious diseases, cancer, inflammation, rare diseases and women’s health, and will include its BioNTech-partnered COVID-19 vaccine Comirnaty as well as oral antiviral therapy Paxlovid (nirmatrelvir/ritonavir).

Vaccines 107

Vaccines 107

Drug Channels

MAY 24, 2022

A few weeks ago, GoodRx surprised investors with the unpleasant news that a major grocery chain had stopped accepting its discount card for an unspecified number of prescriptions. As I explain below, the unnamed chain appears to be Kroger— the sixth-largest U.S. pharmacy. What’s more, GoodRx disclosed that Kroger accounts for an unexpected one-quarter of its prescription business.

98

98

Outsourcing Pharma

MAY 24, 2022

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohnâs.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

MAY 25, 2022

Technology is already being used in clinical trials of new treatments for Alzheimer’s and new studies will provide additional validation

111

111

pharmaphorum

MAY 25, 2022

The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. Since COVID-19 reared its head more than two years ago, the traditional hustle and bustle of in-person annual congresses have largely been consigned to the history books.

Documentation 100

Documentation Communication Pharmaceutical Manufacturing Labelling 100

Outsourcing Pharma

MAY 25, 2022

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.

59

59

Pharma Times

MAY 24, 2022

Less invasive procedure offers an equally effective alternative for heart condition patients

115

115

pharmaphorum

MAY 26, 2022

The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a federal investigation into the murder of a Vermont man in 2018. Serhat Gümrükcü (39) has been charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, along with alleged co-conspirator Berk Eratay (35) of Las Vegas.

Chemotherapy 98

Chemotherapy 98

Drug Patent Watch

MAY 27, 2022

Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are ten patents protecting…. The post New patent for Astrazeneca drug SYMBICORT appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Fusion Pharmacy

MAY 27, 2022

ADHD, or attention-deficit hyperactivity disorder, is a common mental health condition in which individuals have a hard time focusing, have difficulty resisting impulses, and are constantly on the go. The most common treatments for ADHD are prescription medications like Adderall or Ritalin, which can have unwanted side effects like loss of appetite, nausea, headache, and trouble sleeping.

Specialty Pharmacies 52

Specialty Pharmacies 52

Pharma Times

MAY 27, 2022

Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis

113

113

pharmaphorum

MAY 24, 2022

Industrial action at several GlaxoSmithKline manufacturing plants in the UK has been called off, after an improved pay deal was accepted by the Unite union. Unite said last month it was calling for strike by GSK workers for the first time in the company’s history, saying a “derisory” 2.75% pay increase was in fact a pay cut in real terms given the rising rate of inflation in the UK, currently at around 9%.

95

95

Drug Patent Watch

MAY 27, 2022

Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. The generic ingredient…. The post New patent for Antares Pharma drug TLANDO appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Fusion Pharmacy

MAY 26, 2022

Holistic health coaching is a newer kind of service in which a health coach helps you reach your health goals. You may wonder what the difference is between a doctor’s appointment and an appointment with a holistic health coach. Let’s talk about what holistic health coaching is, how it differs from a regular medical checkup, and where you can go to find personalized health coaching in a holistic way.

Specialty Pharmacies 52

Specialty Pharmacies 52

Pharma Times

MAY 26, 2022

Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease

96

96

pharmaphorum

MAY 27, 2022

Digital health company Akili Interactive has agreed a deal that could see its gamified therapy for attention-deficit hyperactivity disorder (ADHD) hosted on the creative gaming platform Roblox, used by around 55 million users worldwide. First launched in 2006, Roblox is an online space where users can play games – more than 20 million of them at a recent count – created by developers and individuals.

93

93

Drug Patent Watch

MAY 27, 2022

Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…. The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Find Your Script

MAY 25, 2022

Are you a student entering pharmacy school? In this video, I’ll talk about my 4 steps to have success in pharmacy school. Stay until the end for my most important step. Watch & Subscribe on our YouTube Channel ! [link]. Hi, I’m Dr. Jessica Louie and I’m an Associate Professor, Board-Certified Critical Care Pharmacist and entrepreneur. I help people find meaning beyond a job title and let go of burnout.

Doctor of Pharmacy 52

Doctor of Pharmacy Community Pharmacies Documentation Hospitals 52

Pharma Times

MAY 23, 2022

Positive opinion is based on data from clinical trials which showed improvement in lung function

102

102

pharmaphorum

MAY 23, 2022

A study that will look at the feasibility of tracking people’s lifestyle habits for an extended period using a wearable device has got underway in Japan, backed by drugmakers Takeda and Daiichi Sankyo. The device will be worn by 2,000 people for a year, harvesting data on sleep status, heart rate, and activity levels, according to the study partners, which also include digital health and telemedicine firm MICIN and Tohoku University.

Pharmaceutical Manufacturing 89

Pharmaceutical Manufacturing 89

Drug Patent Watch

MAY 27, 2022

Annual Drug Patent Expirations for TOSYMRA Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent for Upsher Smith drug TOSYMRA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Board Vitals - Pharmacist

MAY 25, 2022

Physicians and other healthcare professionals are trained to care for others. It’s what we do. In dedicating our lives to caring for others, self-care comes last, and we often put ourselves on the back burner. During training, and in our careers, the default mode is that our own needs come last. That’s embedded into our medical culture. . What if we shifted our focus and treated ourselves as well as we treat those who we love most in the world?

52

52

Pharma Times

MAY 24, 2022

Companies say that three-dose vaccine for children aged six months to five years old is 80% effective at preventing illness

Vaccines 89

Vaccines 89

pharmaphorum

MAY 23, 2022

This article follows part one of our two-part series, in which we discussed how USAID invests in digital infrastructure as part of its development and humanitarian assistance programmes. . Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), discusses the value of establishing donor partnerships and how those collaborations can improve digital health options globally. .

Communication 80

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 80

Drug Patent Watch

MAY 26, 2022

Annual Drug Patent Expirations for REZUROCK Rezurock is a drug marketed by Kadmon Pharms Llc and is included in one NDA. There are four patents protecting this drug. This drug…. The post New patent for Kadmon Pharms drug REZUROCK appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Marketing Network

MAY 24, 2022

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data Video appeared first on Pharma Marketing Network.

52

52

Pharma Times

MAY 27, 2022

Faricimab is administered as an eye injection with an interval of up to 16 weeks

108

108

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. You can read part one of this article here. As the shift to home working proliferated during the pandemic, work became decentralised – and many businesses were able to be productive with a workforce at home.

Packaging 78

Packaging Generic Medicine Communication Hospitals 78

Drug Patent Watch

MAY 26, 2022

Annual Drug Patent Expirations for KISQALI Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…. The post New patent for Novartis drug KISQALI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Marketing Network

MAY 23, 2022

Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post Bharti Rai, Novartis VP & Head of Commercial Acceleration on What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data appeared first on Pharma Marketing Network.

52

52

Pharma Times

MAY 26, 2022

Libtayo has been approved for adults when curative surgery or radiation is not appropriate

102

102

pharmaphorum

MAY 24, 2022

The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the UK top of the table with 56 as of yesterday. Top of the list of concerns is how the virus – which does not spread easily between humans and requires skin-to-skin contact – is spreading so quickly in so many countries in Europe, the Americas and Australia where the disease is not endemic.

Vaccines 77

Vaccines Labelling 77

Drug Patent Watch

MAY 26, 2022

Annual Drug Patent Expirations for KISQALI+FEMARA+CO-PACK+%28COPACKAGED%29 Kisqali Femara Co-pack (copackaged) is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are…. The post New patent for Novartis drug KISQALI FEMARA CO-PACK (COPACKAGED) appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Outsourcing Pharma

MAY 25, 2022

Michelle Keefe, formerly the president of medical affairs and commercial solutions, joined the company in 2017; she also had spent 20 years working for Pfizer.

52

52